Network origin in Liam Eves first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.
14
| Subsidiary | Internet Software/Services | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Liam Eves via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Chairman Director of Finance/CFO Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer | |
| HVIVO PLC | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
| IP GROUP PLC | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| DEEPMATTER GROUP PLC | Packaged Software | Director/Board Member Chief Executive Officer | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Founder | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
Imutex Ltd.
 Imutex Ltd. BiotechnologyHealth Technology Imutex Ltd. is a British company that develops vaccines. The joint venture company is based in London, UK. | Biotechnology | Director/Board Member | |
Morvus Technology Ltd.
 Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
Simbec Research Ltd.
 Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Chief Operating Officer | |
| University of Wales (Bangor) | College/University | Doctorate Degree | |
| The University of Reading | College/University | Undergraduate Degree | |
| VECTURA GROUP | Pharmaceuticals: Major | Chief Operating Officer | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | President | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Henley Management College | College/University | Masters Business Admin | |
| NEPeSMO Ltd. | Chairman | ||
| TISSUE REGENIX GROUP PLC | Medical Specialties | Director/Board Member | |
| DegraSense Ltd. | Director/Board Member | ||
| University of Cambridge | College/University | Undergraduate Degree | |
Angelini Ventures SpA
 Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
| IXICO PLC | Miscellaneous Commercial Services | Director/Board Member | |
Azellon Ltd.
 Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ubiquigent Ltd.
 Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
| Swansea University | College/University | Doctorate Degree | |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Receptor Research Ltd.
 Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| St. Bartholomew's Hospital | Corporate Officer/Principal | ||
OrganOx Ltd.
 OrganOx Ltd. Electronic Equipment/InstrumentsElectronic Technology OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
buyingTeam Ltd.
 buyingTeam Ltd. Miscellaneous Commercial ServicesCommercial Services Buyingteam Ltd. engages in the provision of procurement consultancy and outsourcing services. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Holm Oak Close Management Co. Ltd. | Director/Board Member | ||
| 4D PHARMA PLC | Pharmaceuticals: Major | Chairman | |
ORA Capital Partners Ltd.
 ORA Capital Partners Ltd. Miscellaneous Commercial ServicesCommercial Services ORA Capital Partners Ltd. is a holding and management company whose principal activity is the development and growth of trading companies within its business portfolio. It is currently focused on technology, resources and financial services opportunities. The company operates through two segments: Business Portfolio Return & Advisory Fees and Financial Trading. The Business Portfolio Return & Advisory Fees segment represents gains and losses on the disposal and revaluation of portfolio investments held. The Financial Trading segment uses surplus cash for specific opportunities. It also engages in trading instruments and has smaller interests in a number of other companies. ORA Capital Partners was founded by Richard Ian Griffiths on November 7, 2005 and is headquartered in St. Peter Port, Guernsey. | Miscellaneous Commercial Services | Founder | |
CABI Publishing
 CABI Publishing Publishing: Books/MagazinesConsumer Services CABI Publishing provides publishing services. The company was founded in 1910 and is headquartered in Wallingford, the United Kingdom. | Publishing: Books/Magazines | Chief Executive Officer |
Statistics
International
| United Kingdom | 42 |
| United States | 6 |
| Germany | 2 |
| Bermuda | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 18 |
| Commercial Services | 14 |
| Consumer Services | 9 |
| Finance | 4 |
| Technology Services | 3 |
Operational
| Director/Board Member | 54 |
| Corporate Officer/Principal | 21 |
| Chairman | 15 |
| Director of Finance/CFO | 13 |
| Founder | 12 |
Most connected contacts
- Stock Market
- Insiders
- Liam Eves
- Company connections
